CORALVILLE, Iowa– Global genomics solutions provider Integrated DNA Technologies (IDT) announced it has appointed Linda De Jesus as vice president and general manager, global head of commercial, adding a new leader to the company’s executive team. De Jesus brings over 20 years of international life sciences leadership experience from her diverse career in general management and commercial functions with a track record of successful execution for high-growth businesses spanning pharmaceutical, biopharma, biotechnology and academia. As IDT Global VP and General Manager of Commercial, De Jesus will focus on elevating IDT’s market position and driving future strategic business growth for its expanding portfolio in Genomic Medicine comprised of next generation sequencing (NGS), CRISPR genome editing, synthetic biology and PCR solutions.
“Linda’s tenure in life sciences—coupled with her longstanding history of driving commercial excellence and leading multiple business units across diverse technologies and market segments—will add significant value to IDT’s strategic vision as we continue to accelerate our business strategy, add new capabilities, and serve our customers to enable the greatest genomic breakthroughs,” said IDT President Demaris Mills. “We are pleased that Linda has chosen IDT for the next chapter of her career, committing her customer-centric and pragmatic approach to deliver on IDT’s growth objectives and know that she will reinforce the collaborative agility that has been the hallmark of IDT’s success for more than 30 years.”
Prior to joining IDT, De Jesus was at Azenta Life Sciences where she served as senior vice president and chief commercial officer. In that capacity, she was responsible for the company’s global commercial functions and the integration of go-to-market strategies. She spearheaded the company’s rebranding efforts from Brooks Life Sciences to Azenta Life Sciences, overseeing the launch of its new corporate identity and other high-profile activation efforts. Prior to Azenta, De Jesus was VP and general manager for the Chromatography and Mass Spectrometry division of Thermo Fisher Scientific where she was responsible for a group of business units across consumables, instruments and software. While there, she held multiple senior executive positions including leading one of the largest global commercial roles responsible for $2.5 billion USD and 2,400 employees. De Jesus has an Executive MBA from University of Connecticut, School of Business and a Bachelor of Science in Chemistry from Colombia University.
“It is an incredible honor for me to join IDT and serve a company with such a proud history of innovation. Over the past decades, IDT has set the standard for genomics excellence, and has earned a solid reputation for its world-class products and solutions,” said De Jesus. “We are at an inflection point with new market dynamics and technologies. We now stand at the forefront of innovations in genomic medicine and solutions to shape the industry in advancing therapeutics. I look forward to working with our associates, customers, and partners to accelerate the pace of genomics and enable researchers to rapidly move from the lab to life-changing advancements.”
